Rueda, Oscar M.
Sammut, Stephen-John
Seoane, Jose A.
Chin, Suet-Feung
Caswell-Jin, Jennifer L.
Callari, Maurizio
Batra, Rajbir
Pereira, Bernard
Bruna, Alejandra
Ali, H. Raza
Provenzano, Elena
Liu, Bin
Parisien, Michelle
Gillett, Cheryl
McKinney, Steven
Green, Andrew R.
Murphy, Leigh
Purushotham, Arnie
Ellis, Ian O.
Pharoah, Paul D.
Rueda, Cristina
Aparicio, Samuel
Caldas, Carlos
Curtis, Christina
Article History
Received: 4 July 2018
Accepted: 31 January 2019
First Online: 13 March 2019
Competing interests
: S.A. is founder and shareholder of Contextual Genomic and a scientific advisor to Sangamo Biosciences and Takeda Pharmaceuticals. C. Caldas is a scientific advisor to AstraZeneca-iMed and has received research funding from AstraZeneca, Servier and Genentech/Roche. C. Curtis is a scientific advisory board member and shareholder of GRAIL and consultant for GRAIL and Genentech. A patent application has been filed on aspects of the described work, entitled ‘Methods of treatment based upon molecular characterization of breast cancer’ (C. Curtis, C. Caldas, J.A.S. and O.M.R.).